Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
SelectQuote assumed with an Overweight at Piper Sandler » 04:52
04/06/21
04/06
04:52
04/06/21
04:52
SLQT

SelectQuote

$31.05 /

+1.04 (+3.47%)

Piper Sandler analyst…

Piper Sandler analyst Jeff Garro assumed coverage of SelectQuote with an Overweight rating and $39 price target. The analyst believes SelectQuote has a "differentiated approach" to match consumers with third-party insurers, particularly in the "large and growing" $30B market for Medicare Advantage and Medicare Supplement plans. The company has a "flywheel model that attracts partners with rich products, driving satisfied consumers," Garro tells investors in a research note.

ShowHide Related Items >><<
SLQT SelectQuote
$31.05 /

+1.04 (+3.47%)

03/25/21
Fly Intel: Top five analyst initiations
03/25/21 Goldman Sachs
SelectQuote initiated with a Buy at Goldman Sachs
02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
SLQT SelectQuote
$31.05 /

+1.04 (+3.47%)

  • 04
    Mar
  • 21
    May
SLQT SelectQuote
$31.05 /

+1.04 (+3.47%)

SLQT SelectQuote
$31.05 /

+1.04 (+3.47%)

Initiation
Fly Intel: Top five analyst initiations » 09:53
03/25/21
03/25
09:53
03/25/21
09:53
SLQT

SelectQuote

$26.77 /

+0.02 (+0.07%)

, BW

Babcock & Wilcox

$6.84 /

+0.375 (+5.80%)

, GMBL

Esports Entertainment

$14.50 /

-0.01 (-0.07%)

, GPK

Graphic Packaging

$17.40 /

+0.03 (+0.17%)

, VIRX

Viracta Therapeutics

$8.27 /

+0.23 (+2.86%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. SelectQuote (SLQT) initiated with a Buy at Goldman Sachs. 2. Babcock & Wilcox (BW) initiated with a Buy at DA Davidson and Lake Street. 3. Esports Entertainment (GMBL) initiated with a Buy at Maxim. 4. Graphic Packaging (GPK) initiated with an Overweight at Wells Fargo. 5. Viracta Therapeutics (VIRX) initiated with an Outperform at Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
VIRX Viracta Therapeutics
$8.27 /

+0.23 (+2.86%)

GMBL Esports Entertainment
$14.50 /

-0.01 (-0.07%)

BW Babcock & Wilcox
$6.84 /

+0.375 (+5.80%)

SLQT SelectQuote
$26.77 /

+0.02 (+0.07%)

03/25/21 Goldman Sachs
SelectQuote initiated with a Buy at Goldman Sachs
02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
BW Babcock & Wilcox
$6.84 /

+0.375 (+5.80%)

03/25/21 Lake Street
Babcock & Wilcox initiated with a Buy at Lake Street
03/25/21 DA Davidson
Babcock & Wilcox initiated with a Buy at DA Davidson
02/18/21
Fly Intel: Top five analyst initiations
02/18/21 B. Riley
B. Riley starts Babcock & Wilcox at Buy on strong 'tailwinds'
GMBL Esports Entertainment
$14.50 /

-0.01 (-0.07%)

03/25/21 Maxim
Esports Entertainment initiated with a Buy at Maxim
02/17/21 Noble Capital
Esports Entertainment price target raised to $20 from $11 at Noble Capital
10/28/20 Noble Capital
Esports Entertainment Group initiated with an Outperform at Noble Capital
GPK Graphic Packaging
$17.40 /

+0.03 (+0.17%)

03/25/21 Wells Fargo
Graphic Packaging initiated with an Overweight at Wells Fargo
01/20/21 Deutsche Bank
Graphic Packaging price target raised to $20 from $16 at Deutsche Bank
01/13/21
Fly Intel: Top five analyst initiations
01/13/21 UBS
Graphic Packaging initiated with a Neutral at UBS
VIRX Viracta Therapeutics
$8.27 /

+0.23 (+2.86%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
02/26/21 Oppenheimer
Viracta price target raised to $36 at Oppenheimer after Sunesis merger closing
SLQT SelectQuote
$26.77 /

+0.02 (+0.07%)

GPK Graphic Packaging
$17.40 /

+0.03 (+0.17%)

GMBL Esports Entertainment
$14.50 /

-0.01 (-0.07%)

BW Babcock & Wilcox
$6.84 /

+0.375 (+5.80%)

  • 04
    Mar
  • 10
    Feb
  • 21
    May
GMBL Esports Entertainment
$14.50 /

-0.01 (-0.07%)

SLQT SelectQuote
$26.77 /

+0.02 (+0.07%)

GMBL Esports Entertainment
$14.50 /

-0.01 (-0.07%)

SLQT SelectQuote
$26.77 /

+0.02 (+0.07%)

GMBL Esports Entertainment
$14.50 /

-0.01 (-0.07%)

Initiation
SelectQuote initiated with a Buy at Goldman Sachs » 04:52
03/25/21
03/25
04:52
03/25/21
04:52
SLQT

SelectQuote

$26.75 /

-0.87 (-3.15%)

Goldman Sachs analyst…

Goldman Sachs analyst Yaron Kinar initiated coverage of SelectQuote with a Buy rating and $36 price target, implying 30% upside from the current price. SelectQuote is a "fast-growing," technology-enabled, telesales broker focused on Medicare Advantage enrollment, with a 49% annual revenue growth through fiscal 2023, Kinar tells investors in a research note. The analyst is bullish on the direct-to-consumer Medicare brokerage space.

ShowHide Related Items >><<
SLQT SelectQuote
$26.75 /

-0.87 (-3.15%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
SLQT SelectQuote
$26.75 /

-0.87 (-3.15%)

  • 04
    Mar
  • 21
    May
SLQT SelectQuote
$26.75 /

-0.87 (-3.15%)

SLQT SelectQuote
$26.75 /

-0.87 (-3.15%)

Over a month ago
Syndicate
SelectQuote 10.6M share Secondary priced at $27.50 » 18:32
03/03/21
03/03
18:32
03/03/21
18:32
SLQT

SelectQuote

$28.30 /

-0.25 (-0.88%)

The deal priced below the…

The deal priced below the last closing price of $28.38. Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI and Jefferies are acting as joint book running managers for the offering.

ShowHide Related Items >><<
SLQT SelectQuote
$28.30 /

-0.25 (-0.88%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
SLQT SelectQuote
$28.30 /

-0.25 (-0.88%)

  • 04
    Mar
  • 21
    May
SLQT SelectQuote
$28.30 /

-0.25 (-0.88%)

SLQT SelectQuote
$28.30 /

-0.25 (-0.88%)

Syndicate
SelectQuote announces offering of 10.6M shares of common stock for holders » 16:24
03/01/21
03/01
16:24
03/01/21
16:24
SLQT

SelectQuote

$32.21 /

+1.71 (+5.61%)

SelectQuote announced the…

SelectQuote announced the commencement of a proposed registered secondary public offering of 10.6M shares of common stock by certain stockholders of the company, including entities associated with Brookside Equity Partners and other stockholders of the company. Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital Markets, Barclays, Citigroup, Evercore ISI, and Jefferies are acting as joint bookrunners for this offering. Cantor, Keefe Bruyette & Woods, A Stifel Company, Piper Sandler, and Drexel Hamilton are acting as co-managers for this offering.

ShowHide Related Items >><<
SLQT SelectQuote
$32.21 /

+1.71 (+5.61%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
SLQT SelectQuote
$32.21 /

+1.71 (+5.61%)

  • 21
    May
SLQT SelectQuote
$32.21 /

+1.71 (+5.61%)

SLQT SelectQuote
$32.21 /

+1.71 (+5.61%)

Conference/Events
Citigroup to hold a virtual conference » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
BIO

Bio-Rad

$594.44 /

+0.09 (+0.02%)

, DGX

Quest Diagnostics

$115.77 /

-1.73 (-1.47%)

, DXCM

DexCom

$405.52 /

-1.49 (-0.37%)

, EXAS

Exact Sciences

$135.04 /

-3.84 (-2.76%)

, HOLX

Hologic

$75.15 /

-0.4 (-0.53%)

, JNJ

Johnson & Johnson

$162.61 /

+2.105 (+1.31%)

, MDT

Medtronic

$118.73 /

+0.71 (+0.60%)

, MTD

Mettler-Toledo

$1,126.92 /

+15.75 (+1.42%)

, PEN

Penumbra

$288.57 /

+8.5 (+3.03%)

, PODD

Insulet

$262.39 /

+1.9 (+0.73%)

, SHC

Sotera Health

$26.72 /

+0.28 (+1.06%)

, SLQT

SelectQuote

$30.76 /

+0.795 (+2.65%)

, TECH

Bio-Techne

$374.73 /

-2.58 (-0.68%)

, TNDM

TNDM

/

+

, ZBH

Zimmer Biomet

$163.78 /

+1.96 (+1.21%)

2021 Healthcare Services,…

2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

TNDM TNDM
/

+

TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

PODD Insulet
$262.39 /

+1.9 (+0.73%)

PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DXCM DexCom
$405.52 /

-1.49 (-0.37%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

02/12/21 Citi
Bio-Rad price target raised to $750 from $675 at Citi
02/05/21 Jefferies
Bio-Rad price target raised to $725 from $660 at Jefferies
10/30/20 Citi
Bio-Rad price target raised to $675 from $625 at Citi
10/30/20 Wells Fargo
Bio-Rad price target raised to $650 from $590 at Wells Fargo
DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
10/26/20 Mizuho
Quest Diagnostics price target raised to $149 from $144 at Mizuho
DXCM DexCom
$405.52 /

-1.49 (-0.37%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
02/17/21 SVB Leerink
Exact Sciences price target raised to $180 from $170 at SVB Leerink
02/17/21 Cowen
Exact Sciences price target raised to $180 from $154 at Cowen
HOLX Hologic
$75.15 /

-0.4 (-0.53%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$118.73 /

+0.71 (+0.60%)

02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
02/24/21 Stifel
Medtronic price target raised to $135 after earnings at Stifel
02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
01/04/21 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
PEN Penumbra
$288.57 /

+8.5 (+3.03%)

02/24/21 Canaccord
Penumbra price target raised to $310 from $204 at Canaccord
02/24/21 Wells Fargo
Penumbra price target raised to $310 from $260 at Wells Fargo
02/24/21 Citi
Penumbra price target raised to $325 from $255 at Citi
12/16/20
Fly Intel: Top five analyst downgrades
PODD Insulet
$262.39 /

+1.9 (+0.73%)

02/24/21 Raymond James
Insulet price target raised to $296 from $282 at Raymond James
02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
12/16/20 Citi
Insulet downgraded to Neutral from Buy at Citi
SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
TNDM TNDM
/

+

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

02/09/21 Piper Sandler
Zimmer Biomet multiple should move higher into spin, says Piper Sandler
02/08/21 SVB Leerink
Zimmer Biomet price target raised to $190 from $185 at SVB Leerink
02/08/21 Wells Fargo
Zimmer Biomet price target raised to $176 from $165 at Wells Fargo
02/08/21 Deutsche Bank
Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank
ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

TNDM TNDM
/

+

TECH Bio-Techne
$374.73 /

-2.58 (-0.68%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

PODD Insulet
$262.39 /

+1.9 (+0.73%)

PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DXCM DexCom
$405.52 /

-1.49 (-0.37%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

  • 20
    Nov
  • 28
    May
  • 21
    May
  • 13
    May
PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

SHC Sotera Health
$26.72 /

+0.28 (+1.06%)

PEN Penumbra
$288.57 /

+8.5 (+3.03%)

MTD Mettler-Toledo
$1,126.92 /

+15.75 (+1.42%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DXCM DexCom
$405.52 /

-1.49 (-0.37%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

ZBH Zimmer Biomet
$163.78 /

+1.96 (+1.21%)

SLQT SelectQuote
$30.76 /

+0.795 (+2.65%)

MDT Medtronic
$118.73 /

+0.71 (+0.60%)

JNJ Johnson & Johnson
$162.61 /

+2.105 (+1.31%)

HOLX Hologic
$75.15 /

-0.4 (-0.53%)

EXAS Exact Sciences
$135.04 /

-3.84 (-2.76%)

DGX Quest Diagnostics
$115.77 /

-1.73 (-1.47%)

BIO Bio-Rad
$594.44 /

+0.09 (+0.02%)

Conference/Events
Citigroup to hold a virtual conference » 04:55
02/24/21
02/24
04:55
02/24/21
04:55
BIO

Bio-Rad

$594.35 /

-8.99 (-1.49%)

, DGX

Quest Diagnostics

$117.46 /

+1.24 (+1.07%)

, DXCM

DexCom

$406.68 /

-5.06 (-1.23%)

, EXAS

Exact Sciences

$138.96 /

-3.4 (-2.39%)

, HOLX

Hologic

$75.56 /

+0.96 (+1.29%)

, JNJ

Johnson & Johnson

$160.50 /

-1.265 (-0.78%)

, MDT

Medtronic

$118.01 /

+2.26 (+1.95%)

, MTD

Mettler-Toledo

$1,110.50 /

-24.39 (-2.15%)

, PEN

Penumbra

$280.77 /

+0.9 (+0.32%)

, PODD

Insulet

$261.12 /

+4.25 (+1.65%)

, SHC

Sotera Health

$26.39 /

-0.86 (-3.16%)

, SLQT

SelectQuote

$29.96 /

-0.09 (-0.30%)

, TECH

Bio-Techne

$376.78 /

+0.05 (+0.01%)

, TNDM

TNDM

/

+

, ZBH

Zimmer Biomet

$161.82 /

+1.47 (+0.92%)

2021 Healthcare Services,…

2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

TNDM TNDM
/

+

TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PODD Insulet
$261.12 /

+4.25 (+1.65%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

02/12/21 Citi
Bio-Rad price target raised to $750 from $675 at Citi
02/05/21 Jefferies
Bio-Rad price target raised to $725 from $660 at Jefferies
10/30/20 Citi
Bio-Rad price target raised to $675 from $625 at Citi
10/30/20 Wells Fargo
Bio-Rad price target raised to $650 from $590 at Wells Fargo
DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
10/26/20 Mizuho
Quest Diagnostics price target raised to $149 from $144 at Mizuho
DXCM DexCom
$406.68 /

-5.06 (-1.23%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
02/17/21 SVB Leerink
Exact Sciences price target raised to $180 from $170 at SVB Leerink
02/17/21 Cowen
Exact Sciences price target raised to $180 from $154 at Cowen
HOLX Hologic
$75.56 /

+0.96 (+1.29%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$118.01 /

+2.26 (+1.95%)

02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
01/11/21 Piper Sandler
Medtronic updates thoughts on Q3, products, says Piper Sandler
01/07/21 Morgan Stanley
Axonics price target raised to $58 from $53 at Morgan Stanley
MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
01/04/21 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
PEN Penumbra
$280.77 /

+0.9 (+0.32%)

12/16/20
Fly Intel: Top five analyst downgrades
12/16/20 Wells Fargo
Penumbra price target lowered to $215 from $265 at Wells Fargo
12/16/20 Canaccord
Penumbra price target lowered to $204 from $292 at Canaccord
12/16/20 Citi
Citi keeps Buy rating on Penumbra, says recall 'clearning event'
PODD Insulet
$261.12 /

+4.25 (+1.65%)

02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
12/16/20 Citi
Insulet downgraded to Neutral from Buy at Citi
11/05/20 Wells Fargo
Insulet price target raised to $266 from $250 at Wells Fargo
SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
TNDM TNDM
/

+

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

02/09/21 Piper Sandler
Zimmer Biomet multiple should move higher into spin, says Piper Sandler
02/08/21 SVB Leerink
Zimmer Biomet price target raised to $190 from $185 at SVB Leerink
02/08/21 Wells Fargo
Zimmer Biomet price target raised to $176 from $165 at Wells Fargo
02/08/21 Deutsche Bank
Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

TNDM TNDM
/

+

TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PODD Insulet
$261.12 /

+4.25 (+1.65%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

  • 20
    Nov
  • 28
    May
  • 21
    May
  • 13
    May
PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

Conference/Events
Citigroup to hold a virtual conference » 17:49
02/23/21
02/23
17:49
02/23/21
17:49
BIO

Bio-Rad

$594.35 /

-8.99 (-1.49%)

, DGX

Quest Diagnostics

$117.46 /

+1.24 (+1.07%)

, DXCM

DexCom

$406.68 /

-5.06 (-1.23%)

, EXAS

Exact Sciences

$138.96 /

-3.4 (-2.39%)

, HOLX

Hologic

$75.56 /

+0.96 (+1.29%)

, JNJ

Johnson & Johnson

$160.50 /

-1.265 (-0.78%)

, MDT

Medtronic

$118.01 /

+2.26 (+1.95%)

, MTD

Mettler-Toledo

$1,110.50 /

-24.39 (-2.15%)

, PEN

Penumbra

$280.77 /

+0.9 (+0.32%)

, PODD

Insulet

$261.12 /

+4.25 (+1.65%)

, SHC

Sotera Health

$26.39 /

-0.86 (-3.16%)

, SLQT

SelectQuote

$29.96 /

-0.09 (-0.30%)

, TECH

Bio-Techne

$376.78 /

+0.05 (+0.01%)

, TNDM

TNDM

/

+

, ZBH

Zimmer Biomet

$161.82 /

+1.47 (+0.92%)

2021 Healthcare Services,…

2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference will be held on February 24-25.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

TNDM TNDM
/

+

TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PODD Insulet
$261.12 /

+4.25 (+1.65%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

02/12/21 Citi
Bio-Rad price target raised to $750 from $675 at Citi
02/05/21 Jefferies
Bio-Rad price target raised to $725 from $660 at Jefferies
10/30/20 Citi
Bio-Rad price target raised to $675 from $625 at Citi
10/30/20 Wells Fargo
Bio-Rad price target raised to $650 from $590 at Wells Fargo
DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
10/26/20 Mizuho
Quest Diagnostics price target raised to $149 from $144 at Mizuho
DXCM DexCom
$406.68 /

-5.06 (-1.23%)

02/12/21 Oppenheimer
DexCom price target raised to $449 from $415 at Oppenheimer
02/12/21 Citi
DexCom price target lowered to $480 from $485 at Citi
02/12/21 Piper Sandler
DexCom earnings selloff should be bought, says Piper Sandler
01/29/21 Piper Sandler
DexCom price target raised to $500 from $465 at Piper Sandler
EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

02/18/21 Baird
Exact Sciences price target lowered to $163 from $169 at Baird
02/17/21 Stifel
Exact Sciences price target raised to $165 from $150 at Stifel
02/17/21 SVB Leerink
Exact Sciences price target raised to $180 from $170 at SVB Leerink
02/17/21 Cowen
Exact Sciences price target raised to $180 from $154 at Cowen
HOLX Hologic
$75.56 /

+0.96 (+1.29%)

02/22/21 BTIG
Hologic price target raised to $91 from $84 at BTIG
01/28/21 Wells Fargo
Hologic price target raised to $95 from $90 at Wells Fargo
12/08/20 Argus
Hologic price target raised to $100 from $85 at Argus
11/20/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MDT Medtronic
$118.01 /

+2.26 (+1.95%)

02/23/21 Piper Sandler
Medtronic growth drivers in place after 'mixed' Q3, says at Piper Sandler
01/13/21 Piper Sandler
MCIT finalized rule 'important win' for medical technology, says Piper Sandler
01/11/21 Piper Sandler
Medtronic updates thoughts on Q3, products, says Piper Sandler
01/07/21 Morgan Stanley
Axonics price target raised to $58 from $53 at Morgan Stanley
MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
01/04/21 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
PEN Penumbra
$280.77 /

+0.9 (+0.32%)

12/16/20
Fly Intel: Top five analyst downgrades
12/16/20 Wells Fargo
Penumbra price target lowered to $215 from $265 at Wells Fargo
12/16/20 Canaccord
Penumbra price target lowered to $204 from $292 at Canaccord
12/16/20 Citi
Citi keeps Buy rating on Penumbra, says recall 'clearning event'
PODD Insulet
$261.12 /

+4.25 (+1.65%)

02/04/21 Piper Sandler
Tandem trades at 'significant discount' to Insulet, says Piper Sandler
01/29/21 Piper Sandler
Insulet downgraded to Neutral from Overweight at Piper Sandler
12/16/20 Citi
Insulet downgraded to Neutral from Buy at Citi
11/05/20 Wells Fargo
Insulet price target raised to $266 from $250 at Wells Fargo
SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
12/15/20 Jefferies
Sotera Health initiated with a Buy at Jefferies
SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

02/10/21 Citi
SelectQuote price target raised to $34 from $32 at Citi
02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

02/23/21 Stifel
Stifel upgrades Bio-Techne to Buy, sees strong case for outperformance
02/23/21 Stifel
Bio-Techne upgraded to Buy from Hold at Stifel
02/03/21 Craig-Hallum
Bio-Techne price target raised to $440 from $352 at Craig-Hallum
02/03/21 Citi
Bio-Techne price target raised to $400 from $310 at Citi
TNDM TNDM
/

+

01/21/21 Citi
Citi adds Tandem, removes Guardant from 'Value Creators' list
12/15/20 Wells Fargo
Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up
12/15/20 Wells Fargo
Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

02/09/21 Piper Sandler
Zimmer Biomet multiple should move higher into spin, says Piper Sandler
02/08/21 SVB Leerink
Zimmer Biomet price target raised to $190 from $185 at SVB Leerink
02/08/21 Wells Fargo
Zimmer Biomet price target raised to $176 from $165 at Wells Fargo
02/08/21 Deutsche Bank
Zimmer Biomet price target raised to $160 from $146 at Deutsche Bank
ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

TNDM TNDM
/

+

TECH Bio-Techne
$376.78 /

+0.05 (+0.01%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PODD Insulet
$261.12 /

+4.25 (+1.65%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

  • 20
    Nov
  • 28
    May
  • 21
    May
  • 13
    May
PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

SHC Sotera Health
$26.39 /

-0.86 (-3.16%)

PEN Penumbra
$280.77 /

+0.9 (+0.32%)

MTD Mettler-Toledo
$1,110.50 /

-24.39 (-2.15%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DXCM DexCom
$406.68 /

-5.06 (-1.23%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

ZBH Zimmer Biomet
$161.82 /

+1.47 (+0.92%)

SLQT SelectQuote
$29.96 /

-0.09 (-0.30%)

MDT Medtronic
$118.01 /

+2.26 (+1.95%)

JNJ Johnson & Johnson
$160.50 /

-1.265 (-0.78%)

HOLX Hologic
$75.56 /

+0.96 (+1.29%)

EXAS Exact Sciences
$138.96 /

-3.4 (-2.39%)

DGX Quest Diagnostics
$117.46 /

+1.24 (+1.07%)

BIO Bio-Rad
$594.35 /

-8.99 (-1.49%)

Recommendations
SelectQuote price target raised to $34 from $32 at Citi » 06:34
02/10/21
02/10
06:34
02/10/21
06:34
SLQT

SelectQuote

$26.89 /

+2.56 (+10.52%)

Citi analyst Daniel…

Citi analyst Daniel Grosslight raised the firm's price target on SelectQuote to $34 from $32 and keeps a Buy rating on the shares following the company's fiscal Q2 results.

ShowHide Related Items >><<
SLQT SelectQuote
$26.89 /

+2.56 (+10.52%)

SLQT SelectQuote
$26.89 /

+2.56 (+10.52%)

02/09/21 Evercore ISI
SelectQuote price target raised to $38 from $35 at Evercore ISI
02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
SLQT SelectQuote
$26.89 /

+2.56 (+10.52%)

  • 21
    May
SLQT SelectQuote
$26.89 /

+2.56 (+10.52%)

SLQT SelectQuote
$26.89 /

+2.56 (+10.52%)

Recommendations
SelectQuote price target raised to $38 from $35 at Evercore ISI » 08:27
02/09/21
02/09
08:27
02/09/21
08:27
SLQT

SelectQuote

$24.34 /

-0.605 (-2.43%)

Evercore ISI analyst…

Evercore ISI analyst Elizabeth Anderson raised the firm's price target on SelectQuote to $38 from $35 and keeps an Outperform rating on the shares, noting that the company "had a very strong AEP" but despite robust growth its LTVs remained stable. The Q2 results "come as a relief and further reinforce its differentiated business model," according to Anderson, who adds that she is excited by SelectQuote's continued initiatives to deepen relationships with carriers.

ShowHide Related Items >><<
SLQT SelectQuote
$24.34 /

-0.605 (-2.43%)

SLQT SelectQuote
$24.34 /

-0.605 (-2.43%)

02/09/21 Barclays
SelectQuote price target raised to $36 from $32 at Barclays
10/06/20 Credit Suisse
Walmart entry shows attractiveness of insurance market, says Credit Suisse
10/06/20 Citi
Walmart entry a 'significant competitive threat' to eHealth, says Citi
09/08/20 Credit Suisse
SelectQuote price target lowered to $31 from $38 at Credit Suisse
SLQT SelectQuote
$24.34 /

-0.605 (-2.43%)

  • 21
    May
SLQT SelectQuote
$24.34 /

-0.605 (-2.43%)

SLQT SelectQuote
$24.34 /

-0.605 (-2.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.